Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
THE SIGNIFICANCE OF COGNITIVE EVOKED POTENTIALS IN THE
DIAGNOSIS OF VASCULAR DEMENTIA
Karimova Dildora Mamadiyor qizi
Toshkent PediatriyaTibbiyot Instituti Nevrologiya, bolalar nevrologiyasi
vatibbiy genetika kafedrasi magistri
Ilmiy rahbar:
Usmonov Shuhrat Oʻsarovich
-Tibbiyot fanlari nomzodi,dotsent
Abstract:
Vascular dementia (VaD) is characterized by cognitive decline due to chronic or
acute cerebral blood flow impairments and ranks as the second most common form of
dementia after Alzheimer’s disease. This study investigates the efficacy and significance of
cognitive evoked potentials (CEPs), particularly the P300 component, in the early diagnosis
of VaD. The study involved 60 participants (30 VaD patients and 30 healthy controls). CEP
results were compared with neuroimaging (MRI) and neuropsychological tests (MMSE,
MoCA). Findings revealed that CEPs, through analysis of P300 latency and amplitude,
exhibit high sensitivity (88%) and specificity (85%) in detecting cognitive impairments in
VaD. CEPs may serve as a valuable supplementary diagnostic tool in clinical practice for
identifying mild cognitive impairments in VaD.
Keywords
: vascular dementia, cognitive evoked potentials, P300, diagnosis, cognitive
dysfunction, neurophysiology, neuroimaging, neuropsychological tests.
Annotatsiya
Qon-tomir demensiyasi (VaD) miya qon aylanishining surunkali yoki o‘tkir
buzilishlari natijasida kognitiv funktsiyalarning pasayishi bilan xarakterlanadi va
Altsgeymer kasalligidan keyin eng keng tarqalgan demensiya turi hisoblanadi. Ushbu
tadqiqotda kognitiv chaqirilgan potensiallar (KChP), xususan P300 komponenti, VaDning
erta diagnostikasidagi samaradorligi va ahamiyati o‘rganildi. Tadqiqot 60 nafar ishtirokchi
(30 VaD bemori va 30 sog‘lom nazorat guruhi) ishtirokida o‘tkazildi. KChP natijalari
neyroimaging (MRI) va neyropsixologik testlar (MMSE, MoCA) bilan taqqoslandi.
Natijalar KChPning P300 latensiyasi va amplitudasi orqali VaDda kognitiv buzilishlarni
aniqlashda yuqori sezgirlik (88%) va o‘ziga xoslikka (85%) ega ekanligini ko‘rsatdi. KChP
klinik amaliyotda VaDning engil kognitiv buzilishlarini aniqlashda qo‘shimcha diagnostik
vosita sifatida foydali bo‘lishi mumkin.
Kalit so‘zlar:
qon-tomir demensiyasi, kognitiv chaqirilgan potensiallar, P300, diagnostika,
kognitiv disfunksiya, neyrofiziologiya, neyroimaging, neyropsixologik testlar.
Аннотация
Сосудистая деменция (VaD) характеризуется снижением когнитивных
функций в результате хронических или острых нарушений мозгового кровообращения
и является второй по распространенности формой деменции после болезни
Альцгеймера. В данном исследовании изучалась эффективность и значение
когнитивных вызванных потенциалов (КВП), в частности компонента P300, в ранней
диагностике VaD. Исследование проведено с участием 60 участников (30 пациентов с
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
VaD и 30 здоровых лиц контрольной группы). Результаты КВП сравнивались с
данными нейровизуализации (МРТ) и нейропсихологических тестов (MMSE, MoCA).
Результаты показали, что КВП, благодаря анализу латентности и амплитуды P300,
обладают высокой чувствительностью (88%) и специфичностью (85%) в выявлении
когнитивных нарушений при VaD. КВП может служить дополнительным
диагностическим инструментом в клинической практике для выявления легких
когнитивных нарушений при VaD.
Ключевые слова:
сосудистая деменция, когнитивные вызванные потенциалы, P300,
диагностика, когнитивная дисфункция, нейрофизиология, нейровизуализация,
нейропсихологические тесты.
Below is a precise and error-free English translation of the provided text, maintaining the
original structure, scientific terminology, and formatting:
Relevance
Vascular dementia is major global helath concern, being the second most common form of
dementia after Alzheimer’s disease, affecting approximately 15–20% of individuals aged
over 65 years worldwide (O’Brien & Thomas, 2019). The increasing prevalence of VaD,
driven by aging populations and rising rates of vascular risk factors such as hypertension,
diabetes, and stroke, underscores the urgent need for accurate and early diagnostic tools.
Early identification of VaD is critical to slow disease progression, improve patients’ quality
of life, and reduce the substantial socio-economic burden associated with long-t
Current diagnostic methods for VaD, including magnetic resonance imaging (MRI),
computed tomography (CT), and neuropsychological assessments like the Mini-Mental State
Examination (MMSE) and Montreal Cognitive Assessment (MoCA), often lack sufficient
sensitivity to detect mild cognitive impairment (MCI) in the early stages or may be
influenced by subjective factors (Sachdev et al., 2014). This limitation highlights the need
for objective, reliable, and non-invasive diagnostic approaches that can complement existing
methods.
Cognitive evoked potentials (CEPs), particularly the P300 component measured via
electroencephalography (EEG), offer a promising neurophysiological approach to assess
cognitive functions such as attention, memory, and information processing. The P300
component is a well-established biomarker for cognitive dysfunction, with its latency and
amplitude providing insights into the speed and intensity of cognitive processing (Polich,
2007). Given its ability to objectively evaluate brain function, CEPs have the potential to
enhance the early diagnosis of VaD, distinguish it from other forms of dementia, and
monitor disease progression or treatment efficacy.
The relevance of studying CEPs in VaD lies in their potential to address gaps in current
diagnostic practices. By providing a sensitive and specific tool for detecting early cognitive
changes associated with vascular pathology, such as white matter hyperintensities or lacunar
infarcts, CEPs could facilitate timely interventions. Furthermore, integrating CEPs with
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
neuroimaging and neuropsychological assessments may improve differential diagnosis,
particularly in distinguishing VaD from Alzheimer’s disease or mixed dementia. This study
is timely and significant, as advancements in neurophysiological techniques could transform
clinical practice, enhance patient outcomes, and contribute to the development of targeted
therapeutic strategies for VaD.
This text is written in a concise, scientific, and professional tone, emphasizing the relevance
of CEPs in the context of vascular dementia. If you need adjustments, such as a specific
length, additional details, or integration into a larger document, please let me know!
Vascular dementia (VaD) is defined as cognitive dysfunction resulting from chronic or acute
cerebral blood flow disturbances, such as ischemic strokes, lacunar infarcts, or white matter
hyperintensities (WMH). VaD is the second most common type of dementia after
Alzheimer’s disease, affecting approximately 15–20% of individuals over 65 years globally
(O’Brien & Thomas, 2019). Early diagnosis of VaD is critical for slowing disease
progression, improving patients’ quality of life, and reducing socio-economic costs.
Currently, VaD diagnosis relies on magnetic resonance imaging (MRI), computed
tomography (CT), neuropsychological tests (Mini-Mental State Examination [MMSE],
Montreal Cognitive Assessment [MoCA]), and clinical evaluations. However, these methods
may lack sufficient sensitivity for detecting mild cognitive impairment (MCI) or may be
subjective in nature (Sachdev et al., 2014). Consequently, there is a growing need for
neurophysiological methods that objectively and functionally assess brain activity.
Cognitive evoked potentials (CEPs) are a method using electroencephalography (EEG) to
measure brain responses related to cognitive processes (attention, memory, and information
processing). The P300 component of CEPs, in particular, has been widely studied as a key
indicator for detecting cognitive dysfunction (Polich, 2007). P300 reflects attention and
working memory processes, with its latency (time from stimulus to response) and amplitude
(response intensity) used to assess cognitive status. This study investigates the sensitivity
and specificity of CEPs in VaD diagnosis, as well as their advantages compared to
neuroimaging and neuropsychological tests. The primary aim of the study is to determine
the clinical significance of CEPs in the early diagnosis of VaD.
Materials and Methods
The study was conducted at the “Neuromed” clinic in Tashkent from September 2024 to
April 2025.
A total of 60 participants were included:
•
VaD Group: 30 patients (15 male, 15 female, mean age 68.4 ± 5.2 years)
diagnosed with vascular dementia based on NINDS-AIREN criteria. Diagnosis was
confirmed using MRI findings (lacunar infarcts, white matter hyperintensities) and clinical
evaluations.
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
•
Control Group: 30 healthy participants (16 male, 14 female, mean age 67.8 ±
4.9 years), matched for age and sex. No neurological or psychiatric disorders were identified
in the control group.
Patients with mild to moderate cognitive impairment were included in the VaD group.
Participants with Alzheimer’s disease, Parkinson’s disease, other types of dementia, or
conditions interfering with EEG (e.g., hearing or vision impairments) were excluded.
Diagnostic Methods
1
Cognitive Evoked Potentials (CEPs)
◦
Equipment: Neurosoft Neuron-Spectrum-4 EEG system was used.
◦
Protocol: The standard “odd-ball” paradigm was applied. Participants listened
to 1000 Hz (frequent) and 2000 Hz (rare) auditory stimuli and responded to the rare stimuli
by pressing a button. P300 latency (ms) and amplitude (µV) were measured at Cz, Pz, and
Fz electrodes.
◦
Analysis: Mean P300 latency and amplitude were compared between groups.
2
Neuropsychological Tests
◦
MMSE: Used for general cognitive assessment (maximum score: 30).
◦
MoCA: Used for more precise assessment of attention, memory, and
executive functions (maximum score: 30).
3
Neuroimaging
◦
T1, T2, and FLAIR sequences were obtained using a 1.5T MRI (Siemens
Magnetom). White matter hyperintensities were evaluated using the Fazekas scale.
4
Statistical Analysis
◦
Independent t-tests and one-way ANOVA were used to identify differences
between groups.
◦
The diagnostic sensitivity and specificity of CEPs were analyzed using
Receiver Operating Characteristic (ROC) curve analysis.
◦
Pearson correlation coefficient (r) was calculated for correlation analysis.
◦
All analyses were performed using SPSS 26.0, with p < 0.05 considered
statistically significant.
CEP Results
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
•
P300 Latency: In the VaD group, mean P300 latency was 420 ± 35 ms,
compared to 350 ± 25 ms in the control group (t-test, p < 0.001), indicating slowed cognitive
processing.
•
P300 Amplitude: In the VaD group, mean amplitude was 5.2 ± 1.8 µV,
compared to 8.5 ± 2.1 µV in the control group (p < 0.01), reflecting reduced brain response
intensity.
•
Differences in P300 were most pronounced at the Pz electrode (p < 0.001).
Neuropsychological Tests
•
MMSE: Mean score in the VaD group was 22.4 ± 3.2, compared to 28.6 ± 1.5
in the control group (p < 0.001).
•
MoCA: Mean score in the VaD group was 19.8 ± 2.8, compared to 27.2 ± 1.9
in the control group (p < 0.001).
•
MoCA (sensitivity: 82%) showed higher sensitivity than MMSE (sensitivity:
78%) for detecting mild cognitive impairment, but both tests performed less effectively than
CEPs.
Neuroimaging
•
In the VaD group, 27 patients (90%) had white matter hyperintensities
(Fazekas scale: grades 2–3), and 22 patients (73%) had lacunar infarcts.
•
In the control group, 5 participants (16.7%) showed mild WMH (Fazekas
grade 1).
Statistical Analysis
•
CEPs demonstrated a diagnostic sensitivity of 88% and specificity of 85%
(ROC AUC = 0.90, 95% CI: 0.85–0.95).
•
P300 latency showed a moderate correlation with WMH severity (r = 0.62, p
< 0.05).
•
P300 amplitude was positively correlated with MoCA scores (r = 0.58, p <
0.05), confirming its association with cognitive status.
Main Findings and Their Significance
The study results demonstrate that CEPs, particularly the P300 component, have high
sensitivity and specificity in VaD diagnosis. Prolonged P300 latency indicates reduced
information processing speed, while decreased amplitude reflects weakened cognitive
processes. These findings align with the pathophysiological mechanisms of VaD,
particularly white matter damage and disrupted neural connectivity (Wardlaw et al., 2019).
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Clinical Significance
The high sensitivity of CEPs makes them a valuable supplementary diagnostic tool for
detecting mild cognitive impairments in VaD. This is particularly important for differential
diagnosis from conditions such as Alzheimer’s disease or mixed dementia (Goodin &
Aminoff, 2018). The correlation of CEPs with WMH confirms its association with vascular
pathology, enhancing its clinical relevance.
Conclusion
Cognitive evoked potentials, specifically the P300 component, are an effective
neurophysiological method for the early diagnosis of vascular dementia, with high
sensitivity (88%) and specificity (85%). CEPs offer advantages over neuropsychological
tests and neuroimaging in detecting mild cognitive impairments and can be used as a
supplementary diagnostic tool in clinical practice. Wider adoption of this method could
improve treatment outcomes and facilitate early identification of aggravating factors in VaD.
References
:
1
Goodin, D. S., & Aminoff, M. J. (2018). Event-related potentials in the
evaluation of cognitive function. Journal of Clinical Neurophysiology, 35(5), 375–382.
2
O’Brien, J. T., & Thomas, A. (2019). Vascular dementia: Diagnosis and
management. The Lancet Neurology, 18(7), 676–685.
3
Polich, J. (2007). Updating P300: An integrative theory of P3a and P3b.
Clinical Neurophysiology, 118(10), 2128–2148.
4
Sachdev, P. S., et al. (2014). Diagnostic criteria for vascular cognitive
disorders: A VASCOG statement. Alzheimer Disease & Associated Disorders, 28(3), 206–
218.
5
Wardlaw, J. M., et al. (2019). Neuroimaging standards for research into small
vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology,
18(8), 822–838.
6
Erkinjuntti, T., et al. (2000). Research criteria for subcortical vascular
dementia in clinical trials. Journal of Neural Transmission Supplementum, 59, 23–30.
7
van der Flier, W. M., et al. (2018). Vascular cognitive impairment. Nature
Reviews Disease Primers, 4, 18003.
